Open AccessThe Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease
Author(s) -
Lisa Yue,
Naamah Zitomersky,
Enju Liu,
Sophia Tollefson,
Julia Bender-Stern,
Snehal Naik,
Scott B. Snapper,
Athos Bousvaros
Publication year - 2018
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izy010
Subject(s) - infliximab , medicine , inflammatory bowel disease , antibody , disease , immunology , gastroenterology
The aim of this study was to evaluate the effect of combination therapy with methotrexate or 6-mercaptopurine on infliximab levels (IFXL) and antibodies to infliximab (ATI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom